THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 156 filers reported holding THERAPEUTICSMD INC in Q3 2019. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $4,000 | -90.9% | 11,365 | -90.8% | 0.00% | -100.0% |
Q4 2021 | $44,000 | +63.0% | 123,517 | +236.8% | 0.00% | +100.0% |
Q3 2021 | $27,000 | +800.0% | 36,672 | +1373.4% | 0.00% | – |
Q4 2020 | $3,000 | -25.0% | 2,489 | +63.8% | 0.00% | -100.0% |
Q4 2019 | $4,000 | -83.3% | 1,520 | -77.3% | 0.00% | -85.7% |
Q3 2019 | $24,000 | – | 6,691 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,460,225 | $24,914,000 | 4.95% |
Newtyn Management, LLC | 1,800,000 | $12,960,000 | 1.95% |
1492 Capital Management LLC | 222,485 | $1,602,000 | 1.25% |
SANDERS MORRIS HARRIS LLC | 967,200 | $6,964,000 | 1.18% |
MORGENS WATERFALL VINTIADIS & CO INC | 180,000 | $1,296,000 | 1.15% |
SPHERA FUNDS MANAGEMENT LTD. | 580,000 | $4,176,000 | 0.82% |
Rock Springs Capital Management LP | 1,600,000 | $11,520,000 | 0.66% |
STONERIDGE INVESTMENT PARTNERS LLC | 467,425 | $3,365,000 | 0.45% |
Capital Impact Advisors, LLC | 157,411 | $1,133,000 | 0.45% |
GILDER GAGNON HOWE & CO LLC | 3,059,690 | $22,030,000 | 0.37% |